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Abstract: The last decades have seen an explosive increase in the development of nanoparticles and 
in their use in consumer, industrial and medical applications. Their fast diffusion has also raised 
widespread concern about the potential toxic effects on living organisms, including humans: at the 
nanoscale, they can interact with subcellular components such as membranes, proteins, lipids, 
nucleic acids, thus inducing unpredicted functional perturbations in cells and tissues. The nervous 
tissue is a particular sensitive target, because its cellular components (mainly neurons and glial cells) 
are tightly regulated and metabolically exigent biological entities. While the literature on the 
potential toxicity of nanoparticles has grown in parallel with their utilization, the available data on 
neurotoxicity are less abundant. In particular, information on the neuronal molecular targets of 
nanoparticles is still largely incomplete. A better understanding of this issue is highly relevant for the 
rational and controlled design of nanoparticles, both for their general utilization and more 
specifically for their use in the promising field of nanoneuromedicine. In this review, we will discuss 
the available information on the mechanisms involved in the interaction between nanoobjects and 
cells of the nervous system, focusing on the known molecular actors, both at the plasma membrane 
and in intracellular compartments. 
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1. Introduction 
Nanoparticles (NPs) are defined by having at least one dimension < 100 nm. While some of them 
have always been present in the environment in the form of small size components (ultrafine particles, 
UFPs) of dusts and smokes, their presence has dramatically increased in the last decades due to the 
industrial production of engineered NPs for technological implementations, consumer goods and, of 
specific relevance for the human exposure, for biomedical applications [1]. Due to their size, 
comparable to the dimensions of typical subcellular and molecular structures in the biological 
material, they can interact with living tissues and cells and induce unknown and/or presently not well 
understood alterations of their functions. This new scenario has raised widespread concern about their 
potential toxicity in animals and humans. 
In this review, we will make some reference to the interaction of UFPs, the most widespread 
nanoobjects to which animals and humans are exposed, with the nervous system (NS), but will focus 
specifically on the effects of engineered NPs. 
The literature on the subject has significantly expanded in recent years, and a relevant number of 
excellent and exhaustive reviews is available; only some of the most recent and comprehensive ones 
will be cited here [2–7]. There is a general agreement on the use of the term “potential toxicity”, since, 
while almost all kinds of environmental and engineered NPs have been reported to induce harmful 
effects in living beings, and specifically in the NS, for most of them lack of toxicity has also been 
reported; this criticity depends on several parameters, mainly chemical structure, size, surface 
properties (e.g. charge) and concentration [8–10].  
For nanobiomedical applications, in particular, the task is, therefore, to carefully evaluate the 
range of the above cited parameters that can allow administration to animal and humans for the desired 
use (imaging, drug delivery) without exerting unwanted noxious effects. The range depends on the 
specific particle type and, critically, on the cell/tissue to be targeted. From this point of view, the 
nervous tissue is a highly sensitive and delicate target, due to its strict metabolic requirements and its 
basically non-renewable number of neuronal cells. Considering these critical requirements, a present 
limitation is that the amount of data on potential neurotoxicity of NPs is still less abundant than on 
other tissues. One of the reasons is probably due to the initial uncertainty about the accessibility of NPs 
to the central NS (CNS). Now a consistent set of data, both in vivo and in vitro, confirms that many 
types of NPs can reach the CNS. The two main pathways are by crossing the blood-brain barrier 
(BBB), when administered orally or injected, or through the nasal epithelium to the olfactory bulb and 
the brain, when inhaled [3,5,11,12]. The number of papers on NPs and neurotoxicity is steadily 
growing, even if most of them are based on in vitro experiments, many with high NP 
concentrations [13]. In vivo animal studies have reported morphological and functional alterations in 
several brain regions [14–16], and epidemiological data are mostly based on the correlation between 
exposure to PM (often with incomplete characterization of particle size) and neurological damages and 
behavioral impairments [17].  
In this perspective, the understanding of the mechanisms activated by the interaction between the 
NPs and the biological target, specifically neuronal and glial cells, will be crucial for a more reliable 
evaluation of the safety of specific NPs and nanoobjects. Most of the data available are related to 
effects at the cellular level, the most common being oxidative stress (OS), inflammation, apoptosis, 
changes in gene expression and also epigenetic modifications and genotoxic effects [18–22]. While the 
amount of data on molecular mechanisms activated by NPs and neuronal targets is more limited, it is 
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useful to review the existing knowledge, not only when toxic effects have been reported but also at 
subtoxic doses, based on the finding that the border between toxic and subtoxic effects is not sharp in 
many instances, and on the rationale that the mechanisms activated at different doses may share 
common properties.  
In the present review, we will deal with the effects of NPs on neuronal and glial cells, and will not 
discuss the impact on the endothelial cells that compose the BBB (for an example of these effects, 
see [23]). 
2. NPs and oxidative stress  
As stated above, the most common perturbation elicited by NPs in neurons and glial cells is a 
more or less massive production of reactive oxygen species (ROS) and other reactive molecules, 
leading to OS. The outcome may be the onset of inflammatory responses, with the release of cytokines, 
finally leading to neuronal death, mainly through apoptotic mechanisms [5,24–26]. The production of 
ROS and reactive nitrogen species (RNS) is a process basically active in all cells, including those of 
the CNS. However, its dysregulation can cause damage when production is not counterbalanced by 
scavenging mechanisms. This reflects the delicate border between toxicity and lack of it: when a NP 
induces ROS production, this may not necessarily lead to neuronal damage and neurotoxicity. While 
the agreement on this point is almost universal, less clear are the mechanisms by which interaction of 
NPs with neuronal (or glial) cells induces production of ROS. It is from this issue that our review of the 
NP-activated molecular mechanisms will start. 
2.1. Molecular mechanisms involved in the generation of ROS 
Several reviews list many pathways activated following ROS production, such as activation of 
enzymes and kinases [6,27], oxidation of proteins that leads to their aggregation, oxidation of 
mitochondrial DNA, and also perturbation of calcium homeostasis (see below), but these are all 
downstream targets: where are ROS generated? 
It has been proposed that ROS can be generated by NPs in the extracellular environment [28], 
even if no specific data relative to neuronal or glial cells are presently available; on the other hand NPs 
can interact directly with the plasma membrane, thus activating surface receptors and downstream 
pathways, potentially leading to ROS production [22]; however, also in this case no evidence specific 
for neuronal cells can be found in the literature. 
Most data refer to intracellular targets, activated following NP internalization: enzymes 
responsible for the oxidative balance (such as NADPH oxidase); interaction with mitochondrial 
membranes, leading to their damage and perturbation of the mitochondrial membrane potential, MMP; 
direct production of ROS via Fenton or Fenton-like reactions [6]. 
Before entering into details on the subject of NP-cell interactions and ensuing generation of 
ROS, it should be mentioned that it is generally considered that NPs tend to adsorb on their surface 
proteins and other molecules present in the dispersion medium, forming the so-called protein corona: 
this dynamic structure is involved in the interaction with the plasma membrane, in NPs uptake and, at 
least potentially, in the interaction with surface receptors and activation of signalling 
pathways [6,29–31]. 
4 
 
AIMS Molecular Science  Volume 5, Issue 1, 1–13. 
Cytosolic enzymes involved in ROS production and degradation are potential targets of 
internalized NPs. Cytosolic (and nuclear) localization of glucose-coated Au nanoparticles has been 
reported for neuronal and glial cells [32]. However, data on activation of these pathways by NPs in 
neurons is quite scarce; it has been reported that 25 nm SiO2 NPs (25–200 µg mL−1) induce oxidative 
stress and alfa-synuclein aggregation in PC12 cells by inhibiting the ubiquitin-proteasome 
complex [33]. 
Localization in cellular subcompartments, such as lysosomes, has been characterized in more 
detail [34–36], and in the case of 30 nm TiO2 NPs (5 µM), it can be associated with ROS production 
and changes in expression of proinflammatory cytokine IL-1β [35]. Interestingly, it has been 
reported [37] that the high toxicity of 45 nm iron oxide NPs (3 mM) in microglial cells as compared to 
neurons and astrocytes is a consequence of the strong accumulation of the NPs in the lysosomal 
compartment of the former. 
Data on mitochondrial localization of NPs in cells of the CNS are more abundant [6,38]; most of 
them refer to glial cells and particularly to microglia. TiO2 NPs were shown to generate ROS and 
disturb the mitochondrial machinery in brain microglia (P25; 2.5 ppm) and to induce morphology 
changes, mitochondrial damage, and increase of mitochondrial membrane potential in glial cell lines 
(50 nm; 20 µg cm−2) [39,40]. Conversely, decreased mitochondrial membrane potential and ROS 
production was reported in PC12 cells in the presence of 1–2 nm single-walled carbon nanotubes 
(SWCNTs) at concentrations above 5 µg mL−1 [41,42], in hippocampal neurons of rats exposed to 
5–30 µg mL−1 of 5 nm TiO2 NPs and in rat cortical astrocytes exposed to 25–100 ppm of 20–50 nm 
TiO2 NPs [43,44]. Similar results were obtained with 75 µg mL−1 of 5–30 nm Ag NPs on cultured rat 
cerebellar granule cells [45], but in this case the effects were shown to be dependent on activation 
of surface receptors and perturbation of intracellular calcium homeostasis (see below). Impairment 
of mitochondrial function by Ag NPs has also been reported for brain cortical neurons (20 nm; 
1–10 µg mL−1), SHSY5Y neuroblastoma and D384 astrocytoma cells (70 nm; 15–250 µg mL-1) [11,46]. 
10–50 ppm of 5–45 nm Ag NPs have been shown to cause inhibition of mitochondrial respiratory 
chain complexes I and III in rat brain tissue [47].  
From all these data, it can be concluded that NPs can interfere with mitochondrial functions and 
generate OS either by causing damage of mitochondrial membranes or by perturbing some component 
of the respiratory chain. 
3. Other mechanisms 
3.1. Cytoskeletal proteins  
The cytoskeleton is the backbone of the eukaryotic cell; in neurons and glial cells, its dynamic 
modifications have key roles in development, survival, formation and stabilization of synaptic 
structures and establishment of the correct connections of neuritic processes to form neuronal 
networks. Several reports have addressed the role of several kinds on NPs in perturbing the 
cytoskeletal architecture in cells of the CNS, thus potentially inducing toxicity and cell death. It has 
been found that 1–10 µg mL−1 of 20 nm Ag NPs induce degradation of the key cytoskeletal proteins 
β-tubulin and F-actin in rat cortical neurons in culture [11], resulting in reduced survival of both 
neurons and glial cells, inhibition of neurite growth in developing neurons and degeneration of 
neuronal connections in mature neurons; moreover, they dramatically disrupted synaptic structures, 
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affecting key proteins both at the presynaptic (synaptophysin) and postsynaptic (PSD-95) level. 
Similar effects on microtubule and microfilament proteins, leading to morphological changes and 
reduced cell viability were observed in PC12 cells presented with 0.15–15 mM of 5–12 nm Fe2O3 
NPs [48]. Also, exposure of rat dorsal root ganglia (DRG) neurons to Cu NPs (55–70 nm, 40–100 µM) 
caused disruption of neurite outgrowth [49]. In rat hippocampal neurons, suppression of neurite 
outgrowth by TiO2 NPs (5 nm, 5–30 µg mL-1) was ascribed to a reduced activity of ion channels and 
transporters (see below) and to impairment of glutamate NMDA receptors [50]. Finally, it was found 
that SiO2 NPs (20–50 nm, 25–100 µg mL-1) induced OS and reduction of neurite growth in PC12 
cells [51], thus suggesting a link between OS and cytoskeletal modifications. 
A comprehensive review of the impact of NPs on cytoskeletal neuronal proteins and of the 
underlying mechanisms can be found in [52] 
3.2. Interactions at the plasma membrane: Ion transporters and channels 
The plasma membrane is the first site of interaction between nanoobjects and the cell; before any 
internalization process is initiated, the highly organized lipids and proteins of which it is composed are 
likely targets. In neurons (and glial cells) receptors for neurotransmitters and neurohormones, 
transporters and channels are the main modulators of neuronal activity and of its changes in responses 
to external stimuli. It is therefore to be expected that in these tightly regulated and highly responsive 
cells, NPs can induce significant and potentially damaging effects by interfering with these proteins. 
Some NPs have been shown to regulate the expression of neuronal channels and other proteins 
involved in excitability and neurotransmission [50,52,53]; here, we will discuss in detail only direct 
modulation of the activity of membrane transporters and channels, even if non-specific interactions 
between NPs and phospholipids influencing in turn the activity of membrane proteins cannot be ruled 
out. Moreover, we will not deal with the activation of channels by NPs engineered to be sensitive to 
chemical or physical (such as thermal or magnetic) stimuli (for a recent review on this expanding field, 
see e.g. [54]). 
Data on ion transporters, the main regulators of cytosolic ion homeostasis, are quite scarce. 
Inhibition of Na+-K+, Mg2+ and Ca2+ ATPases in rat brains following administration of Fe2O3 NPs 
have been reported [55]; TiO2 NPs (5 nm, 5–30 µg mL-1) caused a reduction of the activities of Ca2+ 
ATPase and Na+-K+ ATPase in cultured rat hippocampal neurons [50]. Similar effects on the plasma 
membrane of rat retinal ganglion cells Ca2+ ATPase by ZnO NPs (30 nm, 2.5–10 µg mL-1) has been 
reported [56]. 
The most abundant data that have accumulated in recent years refer to ionic channels involved in 
neuronal excitability and synaptic transmission. A list of some of the channels modulated by several 
kinds of NPs can be found in [3]. 
3.3. Voltage operated channels (VOCs) 
Ionic channels whose open or closed state is dependent on the electric potential across the plasma 
membrane are present in many different types of cells, but in neurons they are the key players in the 
generation of self-sustained transient changes in membrane potential (action potentials), the main 
mechanism for coding information in the NS and for its transmission and transfer to other cells. A 
functional perturbation of this class of membrane proteins may potentially disrupt the complex 
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neuronal networks that compose the NS. Below we review the known effects of some type of NPs on 
Na+ and K+ VOCs, reserving a separate paragraph for calcium permeable channels. 
3.3.1. Na+ VOCs 
Channels selectively permeable to Na+ are the prime generators of action potentials (APs) in 
neurons and other electrically excitable cells. Changes in their biophysical properties may influence 
the action potential shape as well as their rate of firing, thus either enhancing or reducing excitability. 
The most direct and reliable way of studying these changes is by means of patch clamp 
electrophysiological recordings [57]. A few papers have reported an increase in the amplitude of the 
current carried by Na+ channels (INa) following in vitro administration of several kinds of NPs: 
5–30 µg mL−1 of 5 nm TiO2 in rat hippocampal neurons [50], 100 µg mL−1 of 20–80 nm ZnO in the 
same preparation [58]. In these two cases, the Authors also reported an increase in amplitude of K+ 
currents: these currents are responsible for the recovery phase of the action potential. For ZnO NPs, the 
combined effects caused an increase in peak amplitude of the AP, a reduction of its duration, and an 
increase in the frequency of AP firing in response to electrical stimulation. On the contrary, inhibitory 
effects on INa have been reported by several groups. In hippocampal rat neurons 10–20 nM of 2.4 nm 
CdSe quantum dots (QDs) induced a shift of the channels to the inactivated state and a reduction of 
available channels [59]. Based on these data, the authors hypothesized that QDs could bind to a 
receptor site at one extracellular end of the voltage-sensing S4 residue of the α subunit, the 
ion-carrying subunit of the channel, thus altering its biophysical properties. Inhibition of INa and 
reduction of AP amplitude was observed in cultured CA1 hippocampal neurons following 
administration of Ag (10 µg mL−1, hydrodinamic diameter 244 nm) and CuO (50 µg mL−1, 
hydrodynamic diameter 246 nm) NPs [60,61]. In the latter case, again, involvement of the S4 residue 
was suggested. Ag NPs (130 µM, 5 nm) caused inhibition of INa and decrease of AP amplitude also in 
mouse chromaffin cells [62].  
3.3.2. K+ VOCs 
In contrast with the two reports cited above [50,58], other groups have described inhibitory 
effects of NPs on K+ currents. In hippocampal neurons, several types of K+-selective channels were 
inhibited by Ag (10 µg mL−1, 224 nm hydrodynamic diameter) [63], tungsten carbide (0.1 µg mL−1, 
5–20 nm) [64], CuO (50 µg mL−1, 60 nm) NPs [65] and by Au nanostars (3 nM, 180 nm) [66]. In the 
last case, an increase in AP firing rate was observed. A suppression of K+ channel activity by 
multi-walled carbon nanotubes (MWCNTs) was observed in PC12 cells [67]. Modification of the 
biophysical properties of calcium-activated K+ channels (BK channels) by MCNTs (30–263 µg mL−1, 
50–100 nm x > 10 µm) has been also reported in chromaffin neurosecretory cells [68]. 
3.4. Calcium permeable channels 
Calcium-permeable channels are a sensitive target, since influx of these ions from the 
extracellular medium is a key regulator of physiological and pathological responses in cells from the 
NS, and disregulation of calcium homeostasis may have a role in neurotoxicity [69]. Even if several 
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papers have reported activation of calcium influx in neuronal and glial cells by NPs (for a review 
see [70]) only a few provide information on the specific type of channel involved. 
3.4.1. Ca2+ VOCs 
Calcium-selective voltage operated channels have a crucial role in coupling electrical activity to 
influx of calcium into the cytosol and in the control of synaptic transmission, gene expression, and 
other key neuronal processes. Despite their importance, very few data are available about the effects of 
their interaction with NPs. In rat hippocampal neurons CdSe QDs (10–20 µg mL−1, 2.4 nm) induced an 
elevation of intracellular calcium concentration, [Ca2+]i, dependent on influx through N-type Ca2+ 
VOCs but also through Na+ channels that in some cases may become permeable to Ca2+ ions, 
indicating a peculiar change in their biophysical properties [71]. Even if not related to a neuronal 
model, it is worth citing that carbon nanotubes (CNTs) have been reported to inhibit neuronal N-type 
channels heterogously expressed; the effect was shown to be dependent on traces of yttrium released 
from the CNTs [72].  
3.4.2. Other Ca2+ channels 
Calcium-permeable cationic channels activated by neurotransmitters, hormones and a vast set of 
chemical and physical stimuli are another ubiquitous and functionally relevant pathway for calcium 
influx. In rat cerebellar granule cells, Ag NPs neurotoxicity is dependent on activation of NMDA 
receptors, a subtype of glutamate receptors forming ion channels permeable to Ca2+ (75 µg mL−1, 
5–30 nm) [45]. An excitatory effect of Ag NPs (10–100 µg mL−1, hydrodynamic diameter 234 nm) 
was also reported in rat CA1 pyramidal neurons at the postsynaptic level [73]; also in this case the 
data suggest an involvement of calcium permeable glutamate receptors. Conversely, TiO2 NPs 
(5–30 µg mL−1, 5 nm) impaired NMDA receptor function in rat hippocampal neurons [50]. A few data 
are available on non-neurotransmitter activated calcium permeable channels: the increase of [Ca2+]i 
induced by SiO2 NPs (20 µg mL−1, 50 nm) was partially blocked by antagonists of TRPV4, a channel 
activated by different mechanical and chemical stimuli [74]; in glial cells (rat cortical astrocytes) 
ultrafine carbon black (10–40 µg cm−2, 124 nm) activated both connexin 43 (Cx43) and pannexin1 
(Panx1) hemichannels [75], large conductance non selective channels involved in the release of ATP 
and other messengers from neurons and glial cells. 
3.4.3. Intracellular calcium channels 
In addition to influx from the extracellular medium, also release from intracellular stores can 
contribute to increases in [Ca2+]i [76]. CdSe QDs (10–20 µg mL−1, 2.4 nm), in addition to the calcium 
influx mechanisms described above, can induce release of Ca2+ ions from stores of the endoplasmic 
reticulum (ER) [71]. The proposed mechanism is as follows: Na+ influx through Na+ VOCs; activation 
of the Na+-Ca2+ exchanger in the mitochondrial membrane, with release of Ca2+ into the cytosol and 
increase of [Ca2+]i; activation of calcium-sensitive ryanodine receptors of the ER, leading to further 
increase in [Ca2+]i via a positive feedback loop. 
Several other reports are available regarding increase of [Ca2+]i induced by NPs, but many of 
them do not describe the molecular players of these responses. Here we will cite two of these papers, 
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because they point to a relevant controversial issue: the relationship between calcium signals and onset 
of OS. Even if OS has been shown to be upstream of activation of several types of neuronal channels, 
including Ca2+ channels [77], the calcium signals activated by Ag NPs (20 µg mL−1, 20–40 nm) in 
mixed neural cell cultures (neurons and astrocytes) were independent on oxidative stress [78]. In this 
context, it must be recalled that contrasting findings are available for the dependence of inhibition of 
other channel types from OS: evidence for a role of ROS in inhibition of INa by Ag NPs (50 µg mL−1, 
hydrodynamic diameter 246 nm) has been provided [61]; on the contrary, in PC12 cells, suppression of 
K+ channel activity by MWCNTs was independent from ROS generation [67]. 
To conclude this section on NPs and ion channel modulation, several other papers have reported 
that NPs can induce perturbations of neuronal electrical activity, excitability and synaptic 
transmission [10,79–82], even if these papers do not provide information on the specific channels 
responsible for the observed effects.  
Conclusions 
Even if the literature on molecular targets activated in cells of the NS by nanoobjects and their 
potential involvement in neurotoxicity is rapidly expanding, the picture is far from being complete. 
More data on the dependence of the described effects on cell type, nanoparticle physicochemical 
characterization (chemical nature, size, surface properties), and concentration, as well as on the 
potential side effects due to the presence of contaminants, are needed. The progress in this field will 
allow a better and rational design of nanoparticles for safe and controlled use, particularly for 
biomedical applications. 
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